Ombajen, Junrel S.
HRN: 26-63-22 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/01/2025
CEFTRIAXONE 1G (VIAL)
02/01/2025
02/07/2025
IV
770mg
Q24hours
PCAP-C
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes